Want to see HK:0255 full AI Analyst Report?
Top Page
Lung Kee (Bermuda) Holdings Limited
(0255)
Select Model
Select Model
Rating:63Neutral
Price Target:
HK$1.50
▼(-9.09% Downside)
Action:Reiterated
Date:08/04/26
The score is driven primarily by mixed financial performance: a very strong, low-leverage balance sheet and generally positive cash generation offset by persistent net losses and contracting revenue. Technicals add modest support with improving short-to-medium trend and neutral momentum, while valuation benefits from the high dividend yield but is tempered by the negative P/E tied to ongoing losses.
Positive Factors
Strong balance sheet (low leverage)
Extremely low leverage gives the company durable financial flexibility: it lowers solvency risk, preserves borrowing capacity, and allows management to fund operations, capex or working-capital needs while executing turnaround measures over the next several months.
Negative Factors
Three years of net losses
Sustained net losses erode retained earnings and limit financial options: they can constrain reinvestment, pressure dividend sustainability, and force cost-cutting or asset sales if profitability isn't restored within a medium-term horizon.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet (low leverage)
Extremely low leverage gives the company durable financial flexibility: it lowers solvency risk, preserves borrowing capacity, and allows management to fund operations, capex or working-capital needs while executing turnaround measures over the next several months.
Read all positive factors
Lung Kee (Bermuda) Holdings Limited (0255) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$893.95M
Dividend Yield14.13%
Average Volume (3M)25.19K
Price to Earnings (P/E)―
Beta (1Y)0.34
Revenue Growth-17.65%
EPS Growth-538.68%
CountryHK
Employees2,800
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)-0.05
Shares Outstanding634,007,300
10 Day Avg. Volume27,600
30 Day Avg. Volume25,192
Financial Highlights & Ratios
PEG Ratio-0.73
Price to Book (P/B)0.70
Price to Sales (P/S)0.82
P/FCF Ratio6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lung Kee (Bermuda) Holdings Limited Business Overview & Revenue Model
Company Description
Lung Kee Group Holdings Limited, an investment holding company, manufactures and markets mould bases and related products in the People's Republic of China and internationally. The company also engages in the property investment and corporate mana...
How the Company Makes Money
The company primarily makes money by selling mould bases and related standard mould components to mould makers and manufacturers that require these parts as inputs for producing injection moulds and die-casting moulds. Revenue is generally generat...
Lung Kee (Bermuda) Holdings Limited Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
82
Very Positive
Cash Flow
66
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.20B | 1.32B | 1.55B | 1.45B | 1.60B | 2.27B |
| Gross Profit | 210.41M | 268.35M | 951.69M | 263.90M | 398.00M | 777.07M |
| EBITDA | 85.80M | 108.90M | 148.58M | 56.87M | 180.74M | 472.05M |
| Net Income | -29.43M | -22.62M | -13.67M | -72.43M | 15.81M | 227.84M |
Balance Sheet | ||||||
| Total Assets | 1.76B | 1.82B | 1.97B | 2.09B | 2.30B | 2.75B |
| Cash, Cash Equivalents and Short-Term Investments | 649.71M | 588.63M | 546.65M | 428.76M | 536.64M | 833.59M |
| Total Debt | 2.79M | 4.36M | 7.83M | 6.57M | 9.56M | 9.02M |
| Total Liabilities | 249.92M | 266.93M | 298.08M | 294.22M | 314.90M | 474.46M |
| Stockholders Equity | 1.51B | 1.55B | 1.67B | 1.80B | 1.99B | 2.27B |
Cash Flow | ||||||
| Free Cash Flow | 221.06M | 173.25M | 190.82M | -35.72M | -93.17M | 168.61M |
| Operating Cash Flow | 257.50M | 213.28M | 226.34M | 77.21M | 89.17M | 369.94M |
| Investing Cash Flow | -16.31M | -27.03M | -24.35M | -98.07M | -170.05M | -193.03M |
| Financing Cash Flow | -128.00M | -165.69M | -67.33M | -73.86M | -168.90M | -277.76M |
Lung Kee (Bermuda) Holdings Limited Technical Analysis
Positive
1.65
Price Trends
1.38
Positive
1.36
Positive
1.37
Positive
Market Momentum
<0.01
Negative
61.33
Neutral
-40.94
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0255, the sentiment is Positive. The current price of 1.65 is above the 20-day moving average (MA) of 1.40, above the 50-day MA of 1.38, and above the 200-day MA of 1.37, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 61.33 is Neutral, neither overbought nor oversold. The STOCH value of -40.94 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0255.
Lung Kee (Bermuda) Holdings Limited Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$1.97B | 24.10 | 13.60% | 0.40% | 37.42% | 124.96% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$893.95M | -30.32 | -1.92% | 14.13% | -17.65% | -538.68% | |
62 Neutral | HK$1.30B | 5.23 | 7.26% | 5.69% | -4.88% | -0.62% | |
54 Neutral | HK$1.39B | 86.88 | 6.05% | ― | -31.18% | -121.38% | |
47 Neutral | HK$299.41M | -6.90 | -3.69% | 4.95% | >-0.01% | 15.55% | |
47 Neutral | HK$547.17M | 47.27 | 0.61% | 5.28% | 23.21% | 11.11% |
* Industrials Sector Average
HK:0255
Lung Kee (Bermuda) Holdings Limited
1.42
-0.01
-1.05%
HK:0822
Ka Shui International Holdings Limited
0.34
-0.01
-4.29%
HK:0838
Eva Precision Industrial Holdings Limited
0.75
-0.28
-27.17%
HK:0929
IPE Group Limited
0.53
-0.03
-5.02%
HK:3816
KFM Kingdom Holdings Ltd.
3.58
3.19
820.31%
HK:2535
WK Group (Holdings) Limited
0.70
0.13
22.81%
Lung Kee (Bermuda) Holdings Limited Corporate Events
Lung Kee Group Sets August Board Meeting to Approve Interim Results and Consider Dividend
Aug 6, 2026
Lung Kee Group Holdings Limited has scheduled a board meeting for 21 August 2026 in Hong Kong to review and approve the group’s interim results for the six months ended 30 June 2026. The board will also consider the payment of an interim div...
Lung Kee Group Updates Bermuda Registered Office Address
Jul 20, 2026
Lung Kee Group Holdings Limited has announced a change to the address of its registered office in Bermuda, effective 3 August 2026, relocating to Richmond House on Par-la-Ville Road in Hamilton. The company confirmed that its branch share registra...
Lung Kee Shareholders Approve All AGM Resolutions, Endorse Dividend and Capital Mandates
May 18, 2026
Lung Kee Group Holdings Limited reported that shareholders approved all resolutions at its 18 May 2026 annual general meeting, including adoption of the 2025 audited financial statements and a final dividend of HK12 cents per share. The meeting sa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.